Histologically confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) Histologically confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the breast Histologically confirmed prostate adenocarcinoma within days prior to randomization. Histologically confirmed adenocarcinoma of the prostate Histologically confirmed prostate adenocarcinoma Histologically confirmed prostate adenocarcinoma Histologically-confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate Histologically confirmed prostate adenocarcinoma at the time of surgery Documented histologically confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate, who meet the following criteria: Histologically confirmed adenocarcinoma of the prostate Histologically documented adenocarcinoma of the prostate Histologically documented adenocarcinoma of the prostate Documented histologically confirmed adenocarcinoma of the prostate Histologically documented adenocarcinoma of the prostate Histologically-confirmed adenocarcinoma of the prostate Documented histologically confirmed adenocarcinoma of the prostate Histologically confirmed prostate adenocarcinoma Histologically confirmed primary non-metastatic adenocarcinoma of the prostate Documented histologically confirmed adenocarcinoma of the prostate Histologically confirmed prostate cancer Histologically confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) Histologically confirmed primary non-metastatic adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate from a prostate biopsy or prostatectomy specimen (primary site), or histological confirmation of adenocarcinoma/carcinoma in a metastatic site of disease in the setting of elevated prostate specific antigen (PSA) and imaging consistent with metastatic prostate cancer, or history of prostate cancer with documented metastasis, or histologically confirmed other solid tumor malignancy, multiple myeloma, or plasmacytoma with pathological confirmation of metastasis Patients must have a histologically confirmed diagnosis of adenocarcinoma of the prostate Histologically-confirmed adenocarcinoma of the prostate All patients must have histologically confirmed prostate adenocarcinoma, with biopsies obtained within twelve months of patient registration Histologically confirmed diagnosis of prostate cancer. Histologically confirmed prostate adenocarcinoma within days of registration Histologically confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate Diagnosis of prostate adenocarcinoma as confirmed by the investigator Histologically confirmed prostate cancer (not exclusive of adenocarcinoma) Histologically confirmed prostate cancer, currently with progressive disease Males with histologically confirmed adenocarcinoma of the prostate Documented histologically confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate Histologically documented adenocarcinoma of the prostate Histologically confirmed metastatic adenocarcinoma of the lung Histologically documented adenocarcinoma of the prostate Histologically confirmed, castrate-resistant adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the rectum Histologically confirmed, locally confined adenocarcinoma of the prostate Histologically documented adenocarcinoma of the prostate Diagnosis of prostate adenocarcinoma as confirmed by the investigator Histologically confirmed, localized adenocarcinoma of the prostate Histologically documented adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate COHORT A: The subject must have histologically confirmed adenocarcinoma of the prostate with tissue confirmation at selected study site Subject has histologically confirmed metastatic adenocarcinoma of the prostate. Patients must have histologically confirmed adenocarcinoma of the prostate gland Histologically confirmed adenocarcinoma of the prostate Participants must have histologically confirmed prostate cancer. Histologically confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) Histologically confirmed adenocarcinoma of the prostate with metastatic disease. Histologically confirmed diagnosis of prostate cancer Histologically confirmed adenocarcinoma of the prostate. Documented histologically confirmed adenocarcinoma of the prostate Documented histologically confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate Documented histologically confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate Histologically-confirmed adenocarcinoma of the prostate Histologically-documented localized (stage < T) prostate adenocarcinoma History of histologically confirmed prostate cancer Histologically confirmed adenocarcinoma of the prostate. Histologically confirmed prostate cancer Histologically confirmed adenocarcinoma of the prostate Histologically confirmed adenocarcinoma of the prostate Histologically-confirmed prostate cancer Patients with histologically confirmed prostate cancer Histologically confirmed primary adenocarcinoma of the prostate Participants must have histologically confirmed prostate cancer Histologically confirmed diagnosis of prostate cancer Histologically confirmed adenocarcinoma of the prostate Patients with histologically confirmed prostate cancer